132 related articles for article (PubMed ID: 6375313)
1. [Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies].
Ohashi T; Tohjoh S; Takeda K; Kumon H; Morioka M; Matsumura Y; Ohmori H; Suyama B; Hironaka K
Hinyokika Kiyo; 1983 Feb; 29(2):141-53. PubMed ID: 6375313
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of urinary ferritin, CEA and beta 2-MG determinations in patients with urinary tract malignancies].
Ohashi T; Tohjoh S; Matsumura Y; Ohmori H; Suyama B; Hironaka K
Hinyokika Kiyo; 1983 Feb; 29(2):131-9. PubMed ID: 6375312
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of CEA levels in lung cancer].
Noge S; Hara N; Ichinose Y; Ishimatsu T; Motohiro A; Etoh K; Miyake J; Ohta M
Gan No Rinsho; 1985 May; 31(6 Suppl):616-22. PubMed ID: 2993691
[TBL] [Abstract][Full Text] [Related]
4. [The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer].
Hamami G
Hinyokika Kiyo; 1983 Oct; 29(10):1231-45. PubMed ID: 6085711
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of tumor markers in breast cancer patients].
Ito T; Tanaka S; Ban K; Sakai N; Oshita H; Oiwa T; Kanno A; Kashizuka T
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2917-23. PubMed ID: 3310907
[TBL] [Abstract][Full Text] [Related]
6. [Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract].
Sanada S; Ogura K; Kiriyama T; Yoshida O
Hinyokika Kiyo; 1985 Aug; 31(8):1299-316. PubMed ID: 4083194
[TBL] [Abstract][Full Text] [Related]
7. [Serum levels and clinical evaluation of CA 19-9 in various diseases].
Toyama K; Noto M; Sakaguchi T; Adachi K; Mitomi H; Okada N; Ootaka H; Nakazawa H; Hara E
Gan No Rinsho; 1985 Mar; 31(3):293-8. PubMed ID: 2582158
[TBL] [Abstract][Full Text] [Related]
8. [What value should be given to assays of serum ferritin in breast cancers? Correlation with various biological parameters].
Dalifard I; Daver A; Cellier P; Larra F
Sem Hop; 1984 Jan; 60(3):157-62. PubMed ID: 6320439
[TBL] [Abstract][Full Text] [Related]
9. CEA and ferritin in chronic pancreatic disease: a comparative evaluation.
Fabris C; Farini R; Piccoli A; Del Favero G; Panucci A; Plebani M; Pedrazzoli S; Nitti D; Naccarato R
Hepatogastroenterology; 1985 Jun; 32(3):146-8. PubMed ID: 4018709
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of serum ferritin levels in urologic cancer (II)].
Washida H; Fushimi N; Tsugaya M
Hinyokika Kiyo; 1983 Jan; 29(1):17-22. PubMed ID: 6677086
[TBL] [Abstract][Full Text] [Related]
11. [Carcinoembryonic antigen assay in serum and pleural effusion of pulmonary malignancies and benign lesions].
Jiang XF; Zhu YJ; Zhao WL; Ma X; Lo WC
Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):430-1. PubMed ID: 3582109
[TBL] [Abstract][Full Text] [Related]
12. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
Tarle M
Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
[TBL] [Abstract][Full Text] [Related]
13. Tumor markers for cancer detection. I.
Pluygers EP; Beauduin MP; Baldewyns PE; Burion JA
Cancer Detect Prev; 1986; 9(5-6):495-504. PubMed ID: 2430704
[TBL] [Abstract][Full Text] [Related]
14. Limits of CEA and ferritin in the diagnosis of pancreatic cancer.
Plebani M; Fabris C; Basso D; Del Favero G; Angonese C; Leandro G; Di Mario F; Burlina A; Naccarato R
Int J Pancreatol; 1988; 3 Suppl 1():S113-7. PubMed ID: 3209864
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen, ferritin, anionic glycoproteins, and their sialic acid content in advanced colorectal cancer.
Cunietti E; Locatelli E; Vaiani G; Gandini R; Gandini MC; Reggiani A; Monti M
Cancer Detect Prev; 1985; 8(1-2):227-32. PubMed ID: 4064042
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
Sakao Y; Tomimitsu S; Takeda Y; Natsuaki M; Itoh T
Eur J Cardiothorac Surg; 2004 Apr; 25(4):520-2. PubMed ID: 15037265
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of urine ferritin determination in urologic malignancies.
Tang DJ; Fan XY; Huang XB; Chen PH; Liang Y; Lang YM
Chin Med J (Engl); 1989 May; 102(5):356-60. PubMed ID: 2509157
[TBL] [Abstract][Full Text] [Related]
18. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of a monoclonal antibody-based enzyme immunoassay (IQ(Bio) PAP-AELIA kit) for prostatic acid phosphatase].
Koshida K; Naito K; Hisazumi H
Hinyokika Kiyo; 1987 Oct; 33(10):1703-7. PubMed ID: 3328502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
